ObinutuzuMab AtezOlizumab and VenetocLax in RichTer transfOrmation
Clinical trial NCT04082897 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04082897
- Sponsor
- Niguarda Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-04
- Primary completion
- 2026-09-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.